Fennec PharmaceuticalsFENC
NASDAQ生物科技
US$10.63+0.28%
关键指标
$225.47M市值
US$9.9252 周最高
US$5.5852 周最低
210,21630 日均量
35 员工数34.48M 流通股本上市日期 2002-01-28
下次财报 ~2026年5月5日
关于 Fennec Pharmaceuticals
Fennec Pharmaceuticals Inc是一家商业化阶段的生物制药公司。其候选产品PEDMARK是一种新配方的硫代硫酸钠，用于预防儿童因顺铂引起的听力损失或耳毒性。公司主要在美国开展业务。
最新新闻
展示全市场股票新闻
Mortgage demand from homebuyers drops 19% from a year ago, as interest rates surge abruptly higher
United States MBA Mortgage Applications dipped from previous -2.7% to -4.1% in September 11
Silver price today, Wednesday, September 16, 2026: Silver prices rise in anticipation of the Fed
Fed now 'firmly expect' 25bp hike, next move is 'deliberately unclear'
Fed decision becomes test of whether 5% Treasuries are monetary or fiscal
Morning Bid: A time to hike?
相关股票生物科技 行业
想看 FENC 的实时 AI 观点?
启动实时多智能体分析室 — Claude、GPT、Gemini、DeepSeek、Grok 和 Qwen 同时分析 FENC,实时输出信号。